Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
04/08/2026 20:58
BRIEF-Lunai Bioworks Signs Agreement With Brainstorm Therapeutics Aug 4 (Reuters) - Lunai Bioworks Inc LNAI.O:
LUNAI BIOWORKS (NASDAQ: LNAI) SIGNS DEFINITIVE COLLABORATION AGREEMENT WITH BRAINSTORM THERAPEUTICS; INITIAL PARKINSON'S DISEASE DATA READOUT TARGETED FOR FIRST HALF OF 2027
LUNAI BIOWORKS - INITIAL PARKINSON'S DISEASE DATA READOUT TARGETED FOR FIRST HALF OF 2027
Source text: ID:nPn8XGGF9a
Further company coverage: LNAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing